-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/asthma-immunotherapy-2010_research-protocol.pdf
January 01, 2010 - Description of the Condition
Allergic rhinitis is a common clinical problem. … Appendix 2 is a description of allergen unitage. … A single year of immunotherapy for ragweed hay fever. Immunologic and clinical studies. … Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1
outcomes of the … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
October 23, 2014 - The
characteristics of the studies are included but further description on the
imaging criteria used
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-protocol-amendment.pdf
November 29, 2023 - intake (e.g., only the
type of protein or source of
protein reported)
Assessment of %AMDR, but no
description … These data fields will include author, year of publication, sponsorship, setting,
study design, population … intake (e.g., only the
type of protein or
source of protein
reported)
Assessment of
%AMDR, but no
description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - ..............................................................................................13
Author … To the best of our knowledge, this analysis is the first description of MTM programs
developed as part … A
four-year analysis of an ambulatory care model. Arch
Intern Med 1984;144(6):1159-62.
14. … Improving
adherence and persistence: a review and assessment of
interventions and description of steps … How often does the plan provide for MTM services (e.g., annually, twice a year,
quarterly)?
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/hypertensive-disorders-pregnancy-protocol-amendment.pdf
April 20, 2022 - than
non-Hispanic White individuals while pregnant, both around the time of delivery and up to 1
year … subsequent, eligible peer-reviewed
publication)
Timing
● Intervention: Day of birth through 1 year … without subsequent, eligible peer-reviewed
publication)
Timing
● Intervention: Day of birth up to 1 year … 1, we will include studies that compared home BP monitoring
during the postpartum period (up to 1 year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/structured-handoff-rapid-research.pdf
January 01, 2025 - A reviewer extracted available information and included author, year, study
design, frequency and severity … outcomes, unintended consequences, implementation
barriers and facilitators, required resources, and description … Evidence table of primary studies included
Author
Year
Country
Handoff
Tool
Co-
interventions … Risk of Bias for RCTs (Cochrane Risk of Bias)
Author,
Year
Random Allocation
Concealment
Blinding … Risk of Bias in Pre-Post Studies
Author,
Year
Were
eligibility/selection
criteria for the study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-monitoring-systems-protocol.pdf
July 01, 2023 - Information will be organized to answer the Review Question and Contextual Questions, and will
include author … , year, study design, frequency and severity of the harms, measures of harm,
characteristics of the … outcomes, unintended consequences, implementation barriers and
facilitators, required resources, and description … Description of the intervention studied;
4. Outcome measures;
5. Outcomes;
6.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/safety-vaccines-protocol.pdf
January 30, 2020 - )
Vaccines routinely used
in the United States
Patient factors:
Age, age groups (e.g.,
>65 year … Searches will be restricted by publication year only for vaccines and vaccine
indications that have … variables that will be used in the review analysis or critical appraisal of the
study:
• Study ID
o Author … and publication year of the main publication, country, PubMed
entry link, trial registration number … medications (including other vaccines) administered concomitantly)
• Control and comparator arms
o Type, description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
April 20, 2015 - resected tumors.[1, 3] It is known that
kidney cancer affects approximately 65,000 new patients each year … stage T1N0M0, ≤ 7 cm in
diameter; stage T2N0M0, > 7 cm in diameter) have excellent outcomes with 5-year … All
extirpative options are associated with an excellent oncologic cure rate (> 95% 5-year disease … exclude studies that:
do not report the health outcomes of
interest
OR
do not give an adequate description … more
Every other uncontrolled study will
get listed in the appendix with the
following data:
Author
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypothyroidism-hyperthyroidism-screening-treatment_research-protocol.pdf
March 11, 2010 - The form allows for
abstraction of the following information:
Extractor, First Author (Last name … , First name), Year of publication, Language, Study
design, Direction of Investigation, Patients, Age … the condition, prevalence and burden, etiology and natural history,
the rationale for screening, a description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-urinary-retention_research-protocol.pdf
November 19, 2012 - These fields will likely include
author; year of publication; setting, subject inclusion and exclusion … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied by a
description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
April 01, 2010 - .................................................................................................6
Description … ............................................................................................35
Author … (The SAS Institute, Cary, NC)
Effective Health Care Research Report Number 21
6
Results
Description … Report Number 21
37
Appendix A: Codes To Identify Chemotherapy Drugs
Chemotherapy Regimen HCPC Description … and Hospital Characteristics
Cancer End-of-Life Quality Benchmark Measures
Data Analysis
Results
Description
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
March 28, 2019 - Peer reviewer
#3
Executive
Summary
Executive summary: Page ES‐1, line 22: The description of the … The description in the methods
has not been revised, as it is written in
accordance with similar systematic … While this strategy has merit, it would be
helpful to present in the results a summary description for … Including a description of cognitive status of the
participants in the trials would be useful.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/arthritis-knee-physical-therapy_disposition-comments.pdf
November 06, 2012 - If this approach is included with the category
of the distribution method, then a better description … The description of the measurement
tools in Table F28 and the definitions of minimal clinically important
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
May 20, 2013 - Background and Objectives for the Systematic Review
Colorectal Cancer
In the United States, each year … 50 years.2
Colorectal cancer is often fatal, with approximately 50,000 deaths attributed to it each year … Summary of existing guidelines for staging colorectal cancer
Clinical Description ACR Recommendations … Source: www.effectivehealthcare.ahrq.gov
Published online: May 20, 2013
6
Clinical Description … Nx: No description of lymph node
involvement is possible because of
incomplete information.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth-disposition-121205.pdf
September 07, 2012 - Reliance of meeting that level in order to note
findings short-circuits the full description of the … Why isn’t daFonseca
included in lines 40-48 of page 33
The description of the studies noted here
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_executive.pdf
June 01, 2012 - Our full report provides a detailed
description of this systematic review.25 We address the
following … rehabilitation
program (8 weeks)
vs. limited home
treatment
Return to gainful
employment at 1 year … difference between
groups
Low
(moderate risk of bias,
single study)
Fitness for military duty
at 1 year … Cognitive-didactic
rehabilitation
programs for
varying durations
Return to gainful
employment at 1-year … Studies we reviewed
demonstrated similar outcomes across treatment groups
at 1-year followup intervals
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-nv-hap-protocol.pdf
August 05, 2024 - ≥100 patients in each arm
• Cross-sectional studies
• Case series
• Case reports
Publication Year … Information will be organized according to the review and contextual questions, and will
include author … , year, study design, care setting, patient population, characteristics of the
PSPs used to prevent … prevalence, timing, severity), implementation barriers and
facilitators, required resources, and description
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
December 05, 2018 - the time of the
survey or pregnant in the prior 12 months), postpartum women (a subset of past-year … Perinatal mental illness: definition, description and aetiology. … First Author & Affiliation: Burke, L.
11. Ashman SB, Dawson G. … First Author & Affiliation:
Field, Tiffany.
13. Beck CT. … First Author & Affiliation: Beck, Cheryl Tatano.
14. O'Connor E, Rossom RC, Henninger M, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
February 23, 2012 - may
vary by key question as appropriate, but the tables will contain some common
elements, such as author … , year of publication, study location (e.g., city, state) and time
period, population description, … limiting the ability to apply interventions to other populations or other settings, such
as inadequate description … Amendments
In the event of protocol amendments, the date of each amendment will be accompanied
by a description